Recent Advances on Platensimycin: A Potential Antimicrobial Agent

Author(s): Xiaoyun Lu, Qidong You

Journal Name: Current Medicinal Chemistry

Volume 17 , Issue 12 , 2010

Become EABM
Become Reviewer
Call for Editor


Platensimycin, an active metabolite of Streptomyces platensis, was initially discovered by a combination of RNA interferin induced gene-silencing and library screening to microbial extracts. Platensimycin selectively inhibits β- ketoacyl-acyl carrier protein (ACP) synthase II (FabF) that is recognized as an effective broad-spectrum antibiotic against drug-resistant microorganism strains. Its novel scaffold and extraordinary antibacterial activity have drawn great attentions in recent years. So far, a number of synthetic strategies have been explored for the total synthesis of platensimycin. Moreover, many analogues have been investigated in terms of structure-activity relationships (SAR). This review provides a detailed overview of updated studies on platensimycin, focusing on various total and formal synthetic strategies, development of analogues, and the structure-activity relationships.

Keywords: Platensimycin, FabF, antibiotic, discovery, platencin, total synthetic strategies, analogues, SAR

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [1139 - 1155]
Pages: 17
DOI: 10.2174/092986710790827852
Price: $65

Article Metrics

PDF: 7